Research and Development: Comparing Key Metrics for International Business Machines Corporation and Manhattan Associates, Inc.

IBM vs. Manhattan: A Decade of R&D Investment

__timestampInternational Business Machines CorporationManhattan Associates, Inc.
Wednesday, January 1, 2014543700000048953000
Thursday, January 1, 2015524700000053859000
Friday, January 1, 2016572600000054736000
Sunday, January 1, 2017559000000057704000
Monday, January 1, 2018537900000071896000
Tuesday, January 1, 2019591000000087608000
Wednesday, January 1, 2020626200000084276000
Friday, January 1, 2021648800000097628000
Saturday, January 1, 20226567000000111877000
Sunday, January 1, 20236775000000126814000
Monday, January 1, 20240137689000
Loading chart...

Unleashing the power of data

A Tale of Two Innovators: IBM vs. Manhattan Associates

In the ever-evolving landscape of technology, research and development (R&D) is the lifeblood of innovation. Over the past decade, International Business Machines Corporation (IBM) and Manhattan Associates, Inc. have demonstrated contrasting approaches to R&D investment. IBM, a titan in the tech industry, has consistently allocated substantial resources to R&D, with expenses peaking at approximately $6.8 billion in 2023, marking a 25% increase since 2014. In contrast, Manhattan Associates, a leader in supply chain solutions, has shown a steady yet modest growth in R&D spending, reaching around $137 million in 2024, a nearly threefold increase from 2014. This disparity highlights IBM's aggressive pursuit of technological advancement, while Manhattan Associates focuses on strategic, incremental innovation. As we look to the future, these trends offer a glimpse into the strategic priorities of these industry leaders.

Published by
U.S. Securities and Exchange Commission

Source link
sec.gov

Date published
28 Jan 2025